LIONEX DIAGNOSTICS AND THERAPEUTICS
Zeitaufgelöste Fluoreszenzdetektion für die integrierte Multiparameter- Analyse von Multiresistenzen beispielgebend bei Tuberkulose
Time-resolved fluorescence detection for integrated multiparameter analysis of multi-resistance in tuberculosis as an example
Multi-resistance has become a significant health problem in fight against infectious diseases. The overall goal of this project is to develope a rapid detection system for multi-resistance using the example of tuberculosis infection.
In the technological part, a photonic platform is being researched that should enable tuberculosis diagnostics outside of a laboratory environment through a high degree of integration. The principle of the detection platform is based on time-resolved fluorescence measurement, with which complex optics and wavelength filters can be dispensed off. This is made possible by the use of ps lasers and single-photon avalanche diode arrays (SPAD), whose switching times are optimized for the detection of short-lived fluorochromes. The platform will also be suitable for other multi-parameter analyses of diagnostics, biotechnology and bio-economy. The molecular-biological-biochemical approach consists of a novel detection method that uses a fluorescence quenching effect to literally illuminate the multi-resistance genes by means of a fluorochrome-binding antibody.
Innovation and perspectives
In particular, the method will improve tuberculosis diagnostics and the determination of multi-resistance and contribute to the containment of the disease through accelerated diagnostics on site. However, it is also quickly adaptable for other multi-resistance detections, such as the acute problem of infections in clinical environments which are often accompanied by signs of resistance. The combination of two innovations, the photonic integration of time-resolved fluorescence measurement for short-lived fluorochromes and the biochemical fluorescence quenching antibody assay, are expected to leads to a new detection technology with which complex analyses, as yet inaccesible, may become greatly simplified and thus widely accessible.
• Lionex GmbH, Braunschweig (Coordinator)
• IMMS GmbH, Ilmenau
• iC-Haus GmbH, Bodenheim
• X-FAB Global Services GmbH, Erfurt
• DITABIS Digital Biomedical Imaging Systems AG, Pforzheim
• Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Potsdam
• Microfluidic ChipShop GmbH, Jena
• Institut für Molekulare Diagnostik und Bioanalytik (IMDB) gGmbH,
Prof. Dr. Mahavir Singh
FLUORESYST is supported by the Bundesministerium für Bildung und Forschung (BMBF)
If you have any question please contact us
© 2018 Lionex GmbH
Last update:Lionex GmbH